These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 10069452

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents.
    Takahashi M, Wakabayashi K.
    Cancer Sci; 2004 Jun; 95(6):475-80. PubMed ID: 15182426
    [Abstract] [Full Text] [Related]

  • 46. Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats.
    Rao CV, Simi B, Wynn TT, Garr K, Reddy BS.
    Cancer Res; 1996 Feb 01; 56(3):532-7. PubMed ID: 8564967
    [Abstract] [Full Text] [Related]

  • 47. The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers.
    DuBois RN, Gupta R, Brockman J, Reddy BS, Krakow SL, Lazar MA.
    Carcinogenesis; 1998 Jan 01; 19(1):49-53. PubMed ID: 9472692
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
    Cardillo MR, Yap E.
    J Exp Clin Cancer Res; 1997 Sep 01; 16(3):281-8. PubMed ID: 9387902
    [Abstract] [Full Text] [Related]

  • 50. Cyclooxygenase-2 alters transforming growth factor-beta 1 response during intestinal tumorigenesis.
    O'Mahony CA, Beauchamp RD, Albo D, Tsujii M, Sheng HM, Shao J, Dubois RN, Berger DH.
    Surgery; 1999 Aug 01; 126(2):364-70. PubMed ID: 10455907
    [Abstract] [Full Text] [Related]

  • 51. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
    Kawamori T, Rao CV, Seibert K, Reddy BS.
    Cancer Res; 1998 Feb 01; 58(3):409-12. PubMed ID: 9458081
    [Abstract] [Full Text] [Related]

  • 52. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound.
    Rao CV, Rivenson A, Simi B, Reddy BS.
    Cancer Res; 1995 Jan 15; 55(2):259-66. PubMed ID: 7812955
    [Abstract] [Full Text] [Related]

  • 53. Down-regulation of PLK3 gene expression by types and amount of dietary fat in rat colon tumors.
    Dai W, Liu T, Wang Q, Rao CV, Reddy BS.
    Int J Oncol; 2002 Jan 15; 20(1):121-6. PubMed ID: 11743651
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
    Hui AY, Dannenberg AJ, Sung JJ, Subbaramaiah K, Du B, Olinga P, Friedman SL.
    J Hepatol; 2004 Aug 15; 41(2):251-8. PubMed ID: 15288474
    [Abstract] [Full Text] [Related]

  • 58. Distal bowel selectivity in the chemoprevention of experimental colon carcinogenesis by the non-steroidal anti-inflammatory drug nabumetone.
    Roy HK, Karolski WJ, Ratashak A.
    Int J Cancer; 2001 May 15; 92(4):609-15. PubMed ID: 11304699
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Enhancement of colon carcinogenesis by prostaglandin E2 administration.
    Kawamori T, Uchiya N, Sugimura T, Wakabayashi K.
    Carcinogenesis; 2003 May 15; 24(5):985-90. PubMed ID: 12771044
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.